Author： Khabriev R. U. Yagudina R. I.
Publisher： Springer Publishing Company
ISSN： 0091-150X
Source： Pharmaceutical Chemistry Journal, Vol.37, Iss.8, 2003-08, pp. : 437-439
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Poluzzi E. Resi D. Zuccheri P. Motola D. De Ponti F. Vaccheri A. Montanaro N.
European Journal of Clinical Pharmacology, Vol. 58, Iss. 1, 2002-04 ,pp. :
Access to resources
Recommend
Pharmacogenetics of drugs withdrawn from the market
By Zhang Wei Roederer Mary W Chen Wang-Qing Fan Lan Zhou Hong-Hao
Pharmacogenomics, Vol. 13, Iss. 2, 2012-01 ,pp. :
Receiving Cytotoxic Drugs—Standard Practice or Russian Roulette?
JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 32, Iss. 3, 2002-09 ,pp. :
Engineering endomorphin drugs: state of the art
By Lazarus Lawrence H Okada Yoshio
Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 1, 2012-01 ,pp. :